Presseschau

18/5/2015

NeoTract, Inc. Announces Excellent Data From Two Studies of the Minimally Invasive UroLift System Treatment for Enlarged Prostate

 

 

30/4/2015

NeoTract Announces Positive Guidelines from European Association of Urology for Minimally Invasive Treatment for Benign Prostatic Hyperplasia

 

 

21/1/2015

NeoTract, Inc. Announces Publication Showing Sustained Safety and Efficacy Benefits for the Minimally Invasive UroLift® System Treatment for Enlarged Prostate

 

 

15/1/2014

Urology Times Supplement
UroLift
® System Treatment: Expert Panel Discussion

 

 

2/6/2014

Perito Urology is NeoTract’s First UroLift® System Training Center of Excellence in the U.S.

 

2/4/2014

NeoTract Announces Aetna US Healthcare and Coventry Health Care Positive Coverage Decision Regarding UroLift® Implant Procedure for Men with Enlarged Prostate

 

13/3/2014

NeoTract’s UroLift® Implant Procedure for Men with Enlarged

Prostate Receives Medicare and Medicaid Outpatient Billing Codes
for Reimbursement

 

29/1/2014

NICE gives go ahead to NeoTract’s groundbreaking UroLift® Prostate Implant that can preserve sexual function while offering urinary symptom relief for millions of men affected by enlarged prostates

 

24/9/2013

First U.S. Patient Treated Following FDA Clearance of NeoTract's UroLift® System

 

16/9/2013

NeoTract, Inc. Receives U.S. FDA De Novo Approval for the UroLift® Prostate Implant

 

7/5/2013

NeoTract's UroLift® Prostate Implant Demonstrates Strong Safety and Efficacy Benefits with Minimally Invasive BPH Treatment

 

© Copyright 2012–2015 NeoTract, Inc. Alle Rechte Vorbehalten.